• Explore /
  • Poster
  • / A phase 1b study of personalized neoantigen vaccine plus pembrolizumab in adults with advanced cancer.

A phase 1b study of personalized neoantigen vaccine plus pembrolizumab in adults with advanced cancer.

Abstract Poster

Authors

null

Aaron Miller

UCSD Moores Cancer Center, La Jolla, CA

Aaron Miller , Zeynep Kosaloglu-Yalcin , Luise Westernberg , Leslie Montero , Milad Bahmanof , Angela Frentzen , Ashmitaa Logandha Ramamoorthy Premlal , Jason Greenbaum , Gregory Seumois , Roxanne Habbaba , Amanda Natsuhara , Kim McConnell , Elaine Eng , Alessandro Sette , Bjoern Peters , Stephen Philip Schoenberger , Ezra E.W. Cohen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Vaccines

Clinical Trial Registration Number

NCT02287428

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2615)

DOI

10.1200/JCO.2021.39.15_suppl.2615

Abstract #

2615

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Mark Yarchoan

First Author: Yang Zhang

First Author: Sofie Kirial Mørk

First Author: Renzo Perales